Exact Mass: 418.1794
Exact Mass Matches: 418.1794
Found 500 metabolites which its exact mass value is equals to given mass value 418.1794
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nimodipine
Nimodipine is a 1,4-dihydropyridine calcium channel blocker. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, nimodipine prevents calcium-dependent smooth muscle contraction and subsequent vasoconstriction. Compared to other calcium channel blocking agents, nimodipine exhibits greater effects on cerebral circulation than on peripheral circulation. Nimodipine is used to as an adjunct to improve the neurologic outcome following subarachnoid hemorrhage from ruptured intracranial aneurysm. C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Lirioresinol A
Syringaresinol is a lignan that is 7,9:7,9-diepoxylignane substituted by hydroxy groups at positions 4 and 4 and methoxy groups at positions 3, 3, 5 and 5 respectively. It has a role as a plant metabolite. It is a lignan, a polyphenol, an aromatic ether, a furofuran and a polyether. Syringaresinol is a natural product found in Dracaena draco, Ficus septica, and other organisms with data available. A lignan that is 7,9:7,9-diepoxylignane substituted by hydroxy groups at positions 4 and 4 and methoxy groups at positions 3, 3, 5 and 5 respectively. Isolated from Artemisia absinthium (wormwood). Lirioresinol A is found in alcoholic beverages and herbs and spices. Lirioresinol A is found in alcoholic beverages. Lirioresinol A is isolated from Artemisia absinthium (wormwood).
2-[4-(3-Hydroxypropyl)-2-methoxyphenoxy]-1,3-propanediol 1-glucoside
2-[4-(3-Hydroxypropyl)-2-methoxyphenoxy]-1,3-propanediol 1-glucoside is found in alcoholic beverages. 2-[4-(3-Hydroxypropyl)-2-methoxyphenoxy]-1,3-propanediol 1-glucoside is a constituent of Riesling wine. Constituent of Riesling wine. 2-[4-(3-Hydroxypropyl)-2-methoxyphenoxy]-1,3-propanediol 1-glucoside is found in alcoholic beverages.
(R)-Byakangelicinn 2'-(3-methylbutanoate)
(R)-Byakangelicinn 2-(3-methylbutanoate) is found in fats and oils. (R)-Byakangelicinn 2-(3-methylbutanoate) is a constituent of angelica (Angelica archangelica) root. Constituent of angelica (Angelica archangelica) root. (R)-Byakangelicinn 2-(3-methylbutanoate) is found in fats and oils, herbs and spices, and green vegetables.
4-O-Methylascochlorin
3-Pyridinemethanamine, 5-(3-(4,6-difluoro-1H-benzimidazol-2-yl)-1H-indazol-5-yl)-N-ethyl-4-methyl-
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Lofepramine
N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
5-O-(2-Methoxyethyl) 3-O-propan-2-yl (4S)-2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate
Vatinoxan
Kuguacin B
Kuguacin b is a member of the class of compounds known as phenol ethers. Phenol ethers are aromatic compounds containing an ether group substituted with a benzene ring. Kuguacin b is practically insoluble (in water) and a moderately basic compound (based on its pKa). Kuguacin b can be found in bitter gourd, which makes kuguacin b a potential biomarker for the consumption of this food product.
(E)-3-(1,3-Benzodioxol-5-yl)-7-[(3,7-dimethyl-2,6-octadienyl)oxy]-4H-1-benzopyran-4-one
Nitiducarpin
3alpha,4alpha-Epoxy-9beta-hydroxy-8beta-(5-acetoxy-tiglinoyloxy)-3,4-dihydro-lasiolaenin
3alpha,4alpha-Epoxy-8beta-hydroxy-9beta-(5-acetoxy-tiglinoyloxy)-3,4-dihydro-lasiolaenin
Warangalone 4-methyl ether
5-O-Methyl-4-O-(3-methylbut-2-enyl)alpinumisoflavone
gangetinin
Flavaspidic acid AB
A polyphenol that is a phloroglucinol derivative isolated from the rhizomes of Dryopteris crassirhizoma and has been shown to exhibit radical scavenging and antibacterial activity.
LOFEPRAMINE
N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
Solvent green 3
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1071
(+)-(7S,8S,8S)-3,4-dihydroxy-2,3,4,5-tetramethoxy-6,9-epoxy-2,7-cyclolignan-9-ol|ovafolinin B
(4R*,8S*,10R*)-1,4-Epoxy-8-tiglyloxy-10-hydroxy-13-acetoxygermacra-1,5E,7(13)-trien-6,12-olide
2-hydroxy-3,4-methylenedioxy-5-prenyl-6,6-dimethylpyrano-[3,4:2,3]-chalcone
1-O-beta-D-Glucopyranoside-2-[4-(3-Hydroxypropyl)-2-methoxyphenoxy]-1,3-propanediol
Pierreione D
A methoxyisoflavone that is isoflavone substituted by a methoxy group at position 3, a prenyloxy group at position 4 and a dimethylpyran ring fused across positions 6 and 7. Isolated from Antheroporum pierrei, it exhibits antineoplastic activity.
2-O-[4-(alpha-hydroxypropyl)-2-methoxyphenyl]-1-O-beta-D-glucopyranosyl glycerol
(1S,5S,7S,8S,9S)-10-chloro-7-hydroxy-1,11-diisovaleroxy-5,6-dihydrovaltrate chlorohydrin|chlorovaltrate J
2-(2,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methyl-2-butenyl)-4H,8H-benzo(1,2-b:3,4-b)dipyran-4-one|morusin
Ala Val Asp Asp
nimodipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Ala Ala Glu Glu
Ala Asp Asp Val
Ala Asp Val Asp
Ala Glu Ala Glu
Ala Glu Glu Ala
Ala Met Pro Thr
Ala Met Thr Pro
Ala Asn Asn Thr
Ala Asn Gln Ser
Ala Asn Ser Gln
Ala Asn Thr Asn
Ala Pro Met Thr
Ala Pro Thr Met
Ala Gln Asn Ser
Ala Gln Ser Asn
Ala Ser Asn Gln
Ala Ser Gln Asn
Ala Thr Met Pro
Ala Thr Asn Asn
Ala Thr Pro Met
Cys Ile Pro Ser
Cys Ile Ser Pro
Cys Leu Pro Ser
Cys Leu Ser Pro
Cys Pro Ile Ser
Cys Pro Leu Ser
Cys Pro Ser Ile
Cys Pro Ser Leu
Cys Pro Thr Val
Cys Pro Val Thr
Cys Ser Ile Pro
Cys Ser Leu Pro
Cys Ser Pro Ile
Cys Ser Pro Leu
Cys Thr Pro Val
Cys Thr Val Pro
Cys Val Pro Thr
Cys Val Thr Pro
Asp Ala Asp Val
Asp Ala Val Asp
Asp Asp Ala Val
Asp Asp Gly Ile
Asp Asp Gly Leu
Asp Asp Ile Gly
Asp Asp Leu Gly
Asp Asp Val Ala
Asp Glu Gly Val
Asp Glu Val Gly
Asp Gly Asp Ile
Asp Gly Asp Leu
Asp Gly Glu Val
Asp Gly Ile Asp
Asp Gly Leu Asp
Asp Gly Val Glu
Asp Ile Asp Gly
Asp Ile Gly Asp
Asp Leu Asp Gly
Asp Leu Gly Asp
Asp Pro Ser Thr
Asp Pro Thr Ser
Asp Ser Pro Thr
Asp Ser Thr Pro
Asp Thr Pro Ser
Asp Thr Ser Pro
Asp Val Ala Asp
Asp Val Asp Ala
Asp Val Glu Gly
Asp Val Gly Glu
Glu Ala Ala Glu
Glu Ala Glu Ala
Glu Asp Gly Val
Glu Asp Val Gly
Glu Glu Ala Ala
Glu Gly Asp Val
Glu Gly Val Asp
Glu Pro Ser Ser
Glu Ser Pro Ser
Glu Ser Ser Pro
Glu Val Asp Gly
Glu Val Gly Asp
Gly Asp Asp Ile
Gly Asp Asp Leu
Gly Asp Glu Val
Gly Asp Ile Asp
Gly Asp Leu Asp
Gly Asp Val Glu
Gly Glu Asp Val
Gly Glu Val Asp
Gly Ile Asp Asp
Gly Leu Asp Asp
Gly Asn Gln Thr
Gly Asn Thr Gln
Gly Gln Asn Thr
Gly Gln Gln Ser
Gly Gln Ser Gln
Gly Gln Thr Asn
Gly Ser Gln Gln
Gly Thr Asn Gln
Gly Thr Gln Asn
Gly Val Asp Glu
Gly Val Glu Asp
Ile Cys Pro Ser
Ile Cys Ser Pro
Ile Asp Asp Gly
Ile Asp Gly Asp
Ile Gly Asp Asp
Ile Pro Cys Ser
Ile Pro Ser Cys
Ile Ser Cys Pro
Ile Ser Pro Cys
Leu Cys Pro Ser
Leu Cys Ser Pro
Leu Asp Asp Gly
Leu Asp Gly Asp
Leu Gly Asp Asp
Leu Pro Cys Ser
Leu Pro Ser Cys
Leu Ser Cys Pro
Leu Ser Pro Cys
Met Ala Pro Thr
Met Ala Thr Pro
Met Pro Ala Thr
Met Pro Thr Ala
Met Thr Ala Pro
Met Thr Pro Ala
Asn Ala Asn Thr
Asn Ala Gln Ser
Asn Ala Ser Gln
Asn Ala Thr Asn
Asn Gly Gln Thr
Asn Gly Thr Gln
Asn Asn Ala Thr
Asn Asn Thr Ala
Asn Gln Ala Ser
Asn Gln Gly Thr
Asn Gln Ser Ala
Asn Gln Thr Gly
Asn Ser Ala Gln
Asn Ser Gln Ala
Asn Thr Ala Asn
Asn Thr Gly Gln
Asn Thr Asn Ala
Asn Thr Gln Gly
Pro Ala Met Thr
Pro Ala Thr Met
Pro Cys Ile Ser
Pro Cys Leu Ser
Pro Cys Ser Ile
Pro Cys Ser Leu
Pro Cys Thr Val
Pro Cys Val Thr
Pro Asp Ser Thr
Pro Asp Thr Ser
Pro Glu Ser Ser
Pro Ile Cys Ser
Pro Ile Ser Cys
Pro Leu Cys Ser
Pro Leu Ser Cys
Pro Met Ala Thr
Pro Met Thr Ala
Pro Ser Cys Ile
Pro Ser Cys Leu
Pro Ser Asp Thr
Pro Ser Glu Ser
Pro Ser Ile Cys
Pro Ser Leu Cys
Pro Ser Ser Glu
Pro Ser Thr Asp
Pro Thr Ala Met
Pro Thr Cys Val
Pro Thr Asp Ser
Pro Thr Met Ala
Pro Thr Ser Asp
Pro Thr Val Cys
Pro Val Cys Thr
Pro Val Thr Cys
Gln Ala Asn Ser
Gln Ala Ser Asn
Gln Gly Asn Thr
Gln Gly Gln Ser
Gln Gly Ser Gln
Gln Gly Thr Asn
Gln Asn Ala Ser
Gln Asn Gly Thr
Gln Asn Ser Ala
Gln Asn Thr Gly
Gln Gln Gly Ser
Gln Gln Ser Gly
Gln Ser Ala Asn
Gln Ser Gly Gln
Gln Ser Asn Ala
Gln Ser Gln Gly
Gln Thr Gly Asn
Gln Thr Asn Gly
Ser Ala Asn Gln
Ser Ala Gln Asn
Ser Cys Ile Pro
Ser Cys Leu Pro
Ser Cys Pro Ile
Ser Cys Pro Leu
Ser Asp Pro Thr
Ser Asp Thr Pro
Ser Glu Pro Ser
Ser Glu Ser Pro
Ser Gly Gln Gln
Ser Ile Cys Pro
Ser Ile Pro Cys
Ser Leu Cys Pro
Ser Leu Pro Cys
Ser Asn Ala Gln
Ser Asn Gln Ala
Ser Pro Cys Ile
Ser Pro Cys Leu
Ser Pro Asp Thr
Ser Pro Glu Ser
Ser Pro Ile Cys
Ser Pro Leu Cys
Ser Pro Ser Glu
Ser Pro Thr Asp
Ser Gln Ala Asn
Ser Gln Gly Gln
Ser Gln Asn Ala
Ser Gln Gln Gly
Ser Ser Glu Pro
Ser Ser Pro Glu
Ser Thr Asp Pro
Ser Thr Pro Asp
Thr Ala Met Pro
Thr Ala Asn Asn
Thr Ala Pro Met
Thr Cys Pro Val
Thr Cys Val Pro
Thr Asp Pro Ser
Thr Asp Ser Pro
Thr Gly Asn Gln
Thr Gly Gln Asn
Thr Met Ala Pro
Thr Met Pro Ala
Thr Asn Ala Asn
Thr Asn Gly Gln
Thr Asn Asn Ala
Thr Asn Gln Gly
Thr Pro Ala Met
Thr Pro Cys Val
Thr Pro Asp Ser
Thr Pro Met Ala
Thr Pro Ser Asp
Thr Pro Val Cys
Thr Gln Gly Asn
Thr Gln Asn Gly
Thr Ser Asp Pro
Thr Ser Pro Asp
Thr Val Cys Pro
Thr Val Pro Cys
Val Ala Asp Asp
Val Cys Pro Thr
Val Cys Thr Pro
Val Asp Ala Asp
Val Asp Asp Ala
Val Asp Glu Gly
Val Asp Gly Glu
Val Glu Asp Gly
Val Glu Gly Asp
Val Gly Asp Glu
Val Gly Glu Asp
Val Pro Cys Thr
Val Pro Thr Cys
Val Thr Cys Pro
Val Thr Pro Cys
2-[4-(3-Hydroxypropyl)-2-methoxyphenoxy]-1,3-propanediol 1-glucoside
2,3,5-Tri-O-benzyl-D-ribonolactone
2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Pregnenolone sulfate sodium salt
Pregnenolone monosulfate sodium (3β-Hydroxy-5-pregnen-20-one monosulfate sodium) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. Pregnenolone monosulfate sodium acts as a signaling-specific inhibitor of cannabinoid CB1 receptor, inhibits the effects of tetrahydrocannabinol (THC) that are mediated by the CB1 receptors. Pregnenolone monosulfate sodium can protect the brain from cannabis intoxication[1][2]. Pregnenolone monosulfate sodium is also a TRPM3 channel activator, and also can weakly activate TRPM1 channels[3]. Pregnenolone monosulfate sodium (3β-Hydroxy-5-pregnen-20-one monosulfate sodium) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. Pregnenolone monosulfate sodium acts as a signaling-specific inhibitor of cannabinoid CB1 receptor, inhibits the effects of tetrahydrocannabinol (THC) that are mediated by the CB1 receptors. Pregnenolone monosulfate sodium can protect the brain from cannabis intoxication[1][2]. Pregnenolone monosulfate sodium is also a TRPM3 channel activator, and also can weakly activate TRPM1 channels[3].
Futibatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor D000970 - Antineoplastic Agents
1-[(4-Chlorophenyl)methyl]-4-[4-(2-methylphenyl)-1-piperazinyl]pyrazolo[3,4-d]pyrimidine
N-[3-[(1-Aminoethyl)(hydroxy)phosphoryl]-2-(1,1-biphenyl-4-ylmethyl)propanoyl]alanine
N-{(2s)-3-[(1r)-1-Aminoethyl](Hydroxy)phosphoryl-2-Benzylpropanoyl}-L-Phenylalanine
5-chloro-2-hydroxy-4-methoxy-6-methyl-3-[(2E,4E)-3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)penta-2,4-dienyl]benzaldehyde
9-cyclopentyl-N(8)-(2-fluorophenyl)-N(2)-(4-methoxyphenyl)-9H-purine-2,8-diamine
2-[[4-(5-Chloro-2-cyclopentyloxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol
[4-(2-Methoxyphenyl)-1-piperazinyl]-[4-[(phenylthio)methyl]phenyl]methanone
5-(3,4-dimethoxyphenyl)-N-[1-[(2-methylphenyl)methyl]-4-pyrazolyl]-3-isoxazolecarboxamide
1-(1-tert-butyl-5-tetrazolyl)-N-(phenylmethyl)-1-(3-pyridinyl)-N-(thiophen-2-ylmethyl)methanamine
N-[(E)-[3-methoxy-4-[2-(4-methylanilino)-2-oxoethoxy]phenyl]methylideneamino]pyridine-3-carboxamide
Ala-Asn-Gln-Ser
A tetrapeptide composed of L-alanyl, L-asparagyl, L-glutamyl, and L-serine residues joined in sequence.
(1R,5S)-7-[4-(2-methylphenyl)phenyl]-3-(3-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane
N,N-dimethyl-3-[4-[(1S,5R)-3-(2-thiazolylmethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide
(1S,5R)-7-[4-(3-methylphenyl)phenyl]-3-(4-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane
(2R,3S,4S)-3-[4-[2-(3-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-[4-oxanyl(oxo)methyl]-2-azetidinecarbonitrile
(2R,3R,4S)-3-[4-[2-(3-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-[4-oxanyl(oxo)methyl]-2-azetidinecarbonitrile
(2S)-2-[(4S,5S)-5-[(dimethylamino)methyl]-4-methyl-1,1-dioxo-8-phenyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5S)-5-[(dimethylamino)methyl]-4-methyl-1,1-dioxo-8-phenyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-5-[(dimethylamino)methyl]-4-methyl-1,1-dioxo-8-phenyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5R)-5-[(dimethylamino)methyl]-4-methyl-1,1-dioxo-8-phenyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-5-[(dimethylamino)methyl]-4-methyl-1,1-dioxo-8-phenyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5S)-5-[(dimethylamino)methyl]-4-methyl-1,1-dioxo-8-phenyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5R)-5-[(dimethylamino)methyl]-4-methyl-1,1-dioxo-8-phenyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5R)-5-[(dimethylamino)methyl]-4-methyl-1,1-dioxo-8-phenyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S,3R,4R)-3-[4-[2-(3-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-[4-oxanyl(oxo)methyl]-2-azetidinecarbonitrile
(1S,5R)-7-[4-(4-methylphenyl)phenyl]-6-(4-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane
(1S,5R)-7-[4-(2-methylphenyl)phenyl]-3-(phenylmethyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane
3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate
N-[(4-chlorophenyl)methyl]-2-[(5Z,8S,12R)-2,9-dioxo-10-oxa-1-azabicyclo[10.3.0]pentadec-5-en-8-yl]acetamide
N-[(4-chlorophenyl)methyl]-2-[(3S,5Z,12R)-2,9-dioxo-10-oxa-1-azabicyclo[10.3.0]pentadec-5-en-3-yl]acetamide
4-(3,6-diaminoacridin-10-ium-10-yl)-N-[2-(2,5-dioxopyrrol-1-yl)ethyl]butanamide
4-{[(1r,2s,3s,4r)-4-(chloromethyl)-4-hydroxy-2-methoxy-3-[(2r,3r)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]cyclohexyl]oxy}-4-oxobutanoic acid
(1r,14r)-3-methoxy-7,7,20,20-tetramethyl-8,12,19,25-tetraoxahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosa-2(11),3,5,9,15(24),16,18(23),21-octaene
(8r,9r)-5-methoxy-8,9-dimethyl-6-(3-methylbut-2-en-1-yl)-4-phenyl-8h,9h-pyrano[2,3-h]chromene-2,10-dione
(2s)-2-(2h-1,3-benzodioxol-5-yl)-8,8-dimethyl-6-(3-methylbut-2-en-1-yl)-2h,3h-pyrano[2,3-f]chromen-4-one
3-(2h-1,3-benzodioxol-5-yl)-1-[5-hydroxy-2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromen-6-yl]prop-2-en-1-one
4-benzyl-9-hydroxy-1-(2-methylbut-3-en-2-yl)-5-oxa-2,16-diazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-triene-3,6-dione
2-[4-(3-hydroxypropyl)-2-methoxyphenoxy]-1,3-propanediol 1-o-glucoside
{"Ingredient_id": "HBIN004206","Ingredient_name": "2-[4-(3-hydroxypropyl)-2-methoxyphenoxy]-1,3-propanediol 1-o-glucoside","Alias": "NA","Ingredient_formula": "C19H30O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10665","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}